In Pennsylvania, Ecolab Life Sciences establishes a new Bioprocessing Applications Lab to aid in the development of biopharmaceutical processes and shorten time to market.

Ecolab Life Sciences has officially launched its new Bioprocessing Technologies Laboratory in Pennsylvania. The new facility is designed to provide extensive technical support to contract manufacturers and biopharmaceutical companies, from small-scale production to full commercial manufacturing. It will help these companies with the purification of biotherapeutic compounds and the development of applications.

In the Eastern United States, this new development site is strategically located near numerous sizable pharmaceutical facilities and a center for bioprocessing innovation. The lab's large-scale column chromatography systems and advanced high-throughput process development technologies enable biotech companies to receive full process development help.

All phases of the development cycle, from early to late stage and commercialization, can be used by large biopharma businesses. Characterizing substitute resins to save production costs and help with regulatory submissions is part of this.

The biopharma industry and contract manufacturing firms are already using this lab to assist improve manufacturing speed and efficiency through lifecycle studies. A quicker path to market is made possible by the lab's ability to start investigations and produce results in a matter of weeks. For openness and collaboration, consumers can also access bench-level processes and raw data.

The new lab is a component of the multi-million dollar company, which also includes a facility for manufacturing excipients and Active Pharmaceutical Ingredients, an interactive learning area, and the Xchange customer experience center. It enhances the Development Lab & Applications and Research that Ecolab already has in Wales, UK.